Evidence map›Paper›PMID 32283700›Full record

ReviewMedicina (Kaunas, Lithuania)2020

Prevalence of

Faten A S Alsulaimany, Zuhier A Awan, Ahmad M Almohamady, Mohammed I Koumu, Bassam E Yaghmoor, Sameh S Elhady, Mahmoud A Elfaky

Registry-linked trialAbstract readReview
In one paragraph

Review in Medicina (Kaunas, Lithuania), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07275827 (Comparative Study Evaluating Safety and Effectiveness of), which is not on this map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07275827 phase3not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Comparative Study Evaluating Safety and Effectiveness of ( Proton Pump Inhibitor Versus Vonoprazan ) Based Triple Therapy With or Without Zinc to Eradicate H. Pylori Infection

TypeinterventionalSponsorTanta UniversityRan2026 to 2026Enrolled88ConditionsHELICOBACTER PYLORI INFECTIONSArmszinc sulfate, Vonoprazan + amoxicillin + clarithromycin, proton pump inhibitor + amoxicillin
3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Molecular Characterization and Genetic Diversity ofDiagnostics (Basel, Switzerland) · 2026
    Article
  2. Clinical validation of a fecal PCR assay forJournal of clinical microbiology · 2026
    Observational
  3. Article
  4. Article
  5. Novel anti-virulence strategy againstFrontiers in microbiology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. The Prevalence ofMedicina (Kaunas, Lithuania) · 2025
    Article
  10. Prevalence, Risk Factors, and Endoscopic Findings ofAntibiotics (Basel, Switzerland) · 2025
    Article
  11. Article
  12. Clinical Pathologic Profiles ofJournal of clinical medicine · 2025
    Article
  13. Article
  14. Article
  15. Novel therapeutic regimens againstFrontiers in microbiology · 2024
    Review
  16. Article
  17. Article
  18. Antimicrobial Resistance Molecular Mechanisms ofAntibiotics (Basel, Switzerland) · 2023
    Article
  19. Article
  20. Expression Assessment of theInternational journal of molecular and cellular medicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Faten A S AlsulaimanyDepartment of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Zuhier A AwanDepartment of Clinical Biochemistry, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Ahmad M AlmohamadyDepartment of Clinical Biochemistry, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Mohammed I KoumuDepartment of Clinical Biochemistry, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Bassam E YaghmoorDepartment of Clinical Biochemistry, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Sameh S ElhadyDepartment of Natural Products, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Mahmoud A ElfakyDepartment of Natural Products, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

PrevalenceAfrica, NorthernDiagnostic Techniques, Digestive SystemHelicobacter InfectionsHelicobacter pyloriHumansMiddle EastRisk FactorsdiagnosisgenotypesHelicobacter pyloriMENAprevalence

Identifiers

PMID32283700
PMCPMC7230269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.